↓ Skip to main content

Case report: inability to achieve a therapeutic dose of tacrolimus in a pediatric allogeneic stem cell transplant patient after generic substitution

Overview of attention for article published in BMC Pharmacology and Toxicology, December 2014
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (75th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

twitter
6 tweeters

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
22 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Case report: inability to achieve a therapeutic dose of tacrolimus in a pediatric allogeneic stem cell transplant patient after generic substitution
Published in
BMC Pharmacology and Toxicology, December 2014
DOI 10.1186/2050-6511-15-69
Pubmed ID
Authors

Ashraf G Madian, Arun Panigrahi, Minoli A Perera, Navin Pinto

Abstract

Tacrolimus is an immunosuppressive drug that is used to lower the activity of the patient's immune system to prevent organ rejection. Unfortunately, there is limited data regarding the therapeutic equivalency of generic tacrolimus formulations especially in children. We report the case of a pediatric patient having an inability to achieve a therapeutic trough level for tacrolimus after conversion from brand name to the generic formulation.

Twitter Demographics

The data shown below were collected from the profiles of 6 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 22 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Australia 1 5%
Unknown 21 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 5 23%
Student > Master 4 18%
Student > Postgraduate 3 14%
Student > Ph. D. Student 3 14%
Student > Doctoral Student 2 9%
Other 4 18%
Unknown 1 5%
Readers by discipline Count As %
Medicine and Dentistry 9 41%
Pharmacology, Toxicology and Pharmaceutical Science 6 27%
Nursing and Health Professions 3 14%
Social Sciences 1 5%
Chemistry 1 5%
Other 0 0%
Unknown 2 9%

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 July 2019.
All research outputs
#4,886,636
of 17,805,015 outputs
Outputs from BMC Pharmacology and Toxicology
#90
of 357 outputs
Outputs of similar age
#77,684
of 317,040 outputs
Outputs of similar age from BMC Pharmacology and Toxicology
#19
of 49 outputs
Altmetric has tracked 17,805,015 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 357 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one has gotten more attention than average, scoring higher than 74% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 317,040 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 75% of its contemporaries.
We're also able to compare this research output to 49 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.